* Lifestance Health Group Inc LFST.OQ LFST.O is expected
to show a rise in quarterly revenue when it reports results on
August 9.
* The Scottsdale Arizona-based company is expected to
report a
21.8% increase in revenue to $255.153 million from $209.53
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Lifestance Health
Group
Inc is for a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Lifestance
Health
Group Inc is $9.5, above its last closing price of $8.99.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.11 -0.11 -0.09 Beat 16.3
Dec. 31 2023 -0.13 -0.13 -0.13 Met -1.3
Sep. 30 2022 -0.13 -0.14 -0.11 Beat 20.5
Jun. 30 2022 -0.15 -0.14 -0.19 Missed -35.7
Mar. -0.20 -0.17 -0.18 Missed -4.7
31 2022
Dec. 31 2021 -0.20 -0.21 -0.33 Missed -55.9
Sep. 30 2021 -0.24 -0.24 -0.35 Missed -45.8
Jun. 30 2021 -0.14 -0.14 -0.22 Missed -57.1
This summary was machine generated August 7 at 18:31 GMT. All
figures in US dollars unless otherwise stated